INS and diabetes mellitus: Furthermore, the depression of plasma glucose and lipid levels in diabetic animals by both sarpogrelate and insulin treatments may represent a shift in substrate utilization by MT to maintain the energy status of the heart as well as to reduce the development of oxidative stress in diabetes.